Serva Health will be exhibiting at DPHARM 2026, taking place September 15 and 16 at the Sheraton Boston. Now in its 16th year, DPHARM brings together more than 1,000 clinical research executives, innovators, patient voices, and technology leaders to explore how clinical trials can become faster, simpler, more accessible, and less burdensome for the people who participate in and operate them.

For Serva Health, those conversations are especially relevant. Patient recruitment and retention increasingly depend on more than identifying potential participants. They require practical ways to support people throughout the trial journey, coordinate communication with sites, manage complex referral pathways, and use technology without losing the human connection that helps participants stay engaged. Serva Health’s own clinical trial model combines nurse-led patient engagement with technology to support recruitment, retention, complex referral management, patient follow-up, and end-to-end tracking.

DPHARM 2026 provides an opportunity to exchange ideas about where those approaches are heading next.

Why DPHARM 2026 Is Worth Watching

DPHARM describes its mission as modernizing clinical research through innovation that improves efficiency and accelerates trials for the benefit of patients. The 2026 program is built around a practical question: how can the industry move promising ideas beyond pilots and into everyday clinical operations?

That emphasis is visible throughout this year’s agenda. Rather than treating innovation as a standalone technology discussion, DPHARM 2026 is focusing on how new operating models, digital tools, artificial intelligence, patient access strategies, and site partnerships can work within real trial environments. The official agenda combines plenary sessions, five tracked program segments, and facilitated roundtables so attendees can explore topics relevant to their own operational priorities.

The conference’s major 2026 themes include:

• Simplifying development and improving operating efficiency
• Moving new technologies from experimentation to scaled execution
• Applying AI and automation to practical clinical operations use cases
• Reducing operational bottlenecks and site burden
• Expanding trial access through community-based research models
• Advancing clinical data management and digital health technologies

Together, those themes point toward an important shift in clinical research: innovation is increasingly being evaluated not by how new it is, but by whether it makes trials work better for patients, sites, and study teams.

From Innovation to Practical Clinical Trial Execution

One of the most interesting aspects of the DPHARM 2026 conference is its emphasis on implementation.

The agenda includes discussions about what “real-time” clinical trials could look like, how organizations can make AI operational at scale, and what infrastructure, validation, governance, and trust are needed before emerging technologies can reliably support clinical development. Other sessions examine the challenge of doing more with limited clinical operations resources and the need to simplify workflows before adding new tools.

Change management is also receiving attention. One DPHARM 2026 keynote will examine why adopting an innovation across an organization can take years even after leadership decides to move forward, with a focus on the processes and organizational changes required to turn new approaches into routine practice.

That is particularly relevant to patient engagement. Technology can automate tasks, organize information, support communication, and give study teams greater visibility, but participant-facing processes still have to work in the real world. A recruitment workflow only creates value if interested patients can navigate it. A retention strategy only succeeds if participants remain informed and supported. A digital tool only reduces burden when it fits naturally into the experiences of patients and sites.

Serva Health’s clinical trial services are designed around that intersection of technology and human support, including patient pre-screening and referrals, complex referral management, medical-record retrieval, pre-referral scheduling, site support, follow-up, tracking, and retention programs.

Keeping Patients and Sites at the Center

Technology will be a major part of DPHARM 2026, but the conference is not framing modernization as technology alone.

The 2026 program explicitly identifies reducing patient, site, and physician burden as part of its focus, while another theme centers on expanding access and embedding more research within community healthcare settings. Patient advocates and people with lived clinical trial experience are also represented within the program.

These issues are connected. A trial can have sophisticated technology and still create friction if participants have difficulty understanding the next step, connecting with the right site, completing pre-referral requirements, coordinating appointments, or getting answers when circumstances change.

The same is true for sites. Adding another platform or communication channel does not necessarily reduce work unless the surrounding workflow is designed to remove unnecessary tasks.

That is why conversations around patient engagement, site support, recruitment, retention, and operational simplicity at DPHARM are worth following. The real opportunity is not simply digitizing an existing process. It is finding places where thoughtful technology and high-touch support can make participation easier while helping research teams operate more efficiently.

Building on the Conversations From DPHARM 2025

The focus on practical implementation did not begin this year.

A recap of DPHARM 2025 described an event centered on making clinical trials faster and more efficient through collaboration, AI and automation, protocol simplification, patient-centered approaches, and changes to clinical operating models. Approximately 1,000 professionals participated in last year’s conference.

Among the recurring questions were how to reduce protocol complexity, use technology without creating additional burden, improve patient-centric trial services, and introduce automation in areas where it can produce meaningful operational improvements.

Those conversations provide useful context for DPHARM 2026. This year’s program appears to push the discussion further toward scale and execution, including how organizations decide which innovations are ready for broader adoption and how they measure whether those changes are actually improving clinical research.

For anyone who wants a deeper look at how those themes developed, the DPHARM 2025 recap from Fierce Pharma provides additional context on the ideas and operational challenges that shaped last year’s meeting.

Meet Serva Health at DPHARM 2026

Serva Health will be on site with a booth throughout DPHARM 2026, and we look forward to connecting with clinical operations, patient engagement, recruitment, retention, and innovation leaders in Boston.

Our team is especially interested in the conversations happening around reducing patient and site burden, making recruitment pathways easier to navigate, supporting participants after enrollment, and finding the right balance between technology-enabled efficiency and meaningful human interaction.

These priorities closely reflect Serva Health’s approach to clinical trial patient engagement. Our clinical services combine a global nurse call center with technology-enabled workflows designed to support patients across the recruitment and retention journey, including complex referrals, site coordination, follow-up, and longitudinal patient tracking.

Looking Ahead to Boston

DPHARM 2026 takes place September 15 and 16, 2026, at the Sheraton Boston. The conference is expected to bring together more than 1,000 industry executives, innovators, patient voices, and clinical research leaders for two days focused on modernizing how trials are designed and executed.

For Serva Health, the most valuable discussions will be the ones that connect innovation back to the people clinical research depends on: patients, caregivers, sites, and study teams.

We look forward to being part of those conversations at DPHARM 2026 and seeing where the clinical research community takes them next.